… of COVID-19. This study evaluates the efficacy and safety of molnupiravir in addition to …
standard-of-care (SOC) for the treatment of non-hospitalized patients with mild COVID-19. …

… the effectiveness and safety of azvudine in older adults with mild or moderate COVID-19. …
aimed to explore the effectiveness and safety of azvudine in older adults with mild or moderate …

… The primary end point was the efficacy of the NVX-CoV2373 vaccine against the first occurrence
of virologically confirmed symptomatic mild, moderate, or severe Covid-19 with onset at …

… efficacy and safety of Favipiravir in treatment of COVID-19 … All clinical trials which addressed
the safety and efficacy of … group of patients with mild to moderate COVID-19. We should …

… In this randomized, double-blinded, multicentre, and placebo-controlled trial, adults with
PCR-confirmed mild COVID-19 were recruited in an outpatient setting at seven medical facilities …

… efficacy of FNC added to standard treatment, compared with placebo group added to standard
treatment, for patients with mild COVID-19. … treatment in the mild COVID-19 patients may …

Frontiers | Efficacy and safety of chinese herbal medicine for treating mild or moderate
COVID-19: A systematic review and meta-analysis of randomized controlled trials and …

… efficacy, 56.3%; 95% confidence interval [CI], 51.3 to 60.8) (Table 1). Vaccine efficacy against
moderate to severe–critical Covid-19 … , with only 10 cases of mild Covid-19 occurring in the …

… Pfizer announces additional phase 2/3 study results confirming robust efficacy of novel
COVID-19 oral antiviral treatment candidate in reducing risk of hospitalization or death. Press …

… More data are needed to establish the standard of care for patients with mild or moderate …
are under way to assess their safety and efficacy in preventing Covid-19. It is unknown whether …